Interpace Biosciences

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch IDXG and buy or sell other stocks, options, and ETFs commission-free!

About IDXG

Interpace Biosciences, Inc. operates as an bioinformatics company, which engages in the development and commercialization of molecular diagnostic test and pathology services. It offers PancraGEN, a pancreatic cyst and pancreaticobiliary solid lesion molecular test that can aid in pancreatic cyst diagnosis and pancreatic cancer risk assessment; ThyGenX and PathFinderTG which assesses thyroid nodules for risk of malignancy; and ThyraMIR, which assesses thyroid nodules for risk of malignancy utilizing a proprietary gene expression assay. 

CEO
Jack E. Stover
CEOJack E. Stover
Employees
89
Employees89
Headquarters
Parsippany, New Jersey
HeadquartersParsippany, New Jersey
Founded
1986
Founded1986
Employees
89
Employees89

IDXG Key Statistics

Market cap
57.29M
Market cap57.29M
Price-Earnings ratio
0.00
Price-Earnings ratio0.00
Dividend yield
Dividend yield
Average volume
573.44K
Average volume573.44K
High today
$1.53
High today$1.53
Low today
$1.43
Low today$1.43
Open price
$1.53
Open price$1.53
Volume
615.00
Volume615.00
52 Week high
$1.53
52 Week high$1.53
52 Week low
$0.381
52 Week low$0.381
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.